A Peek at Champions Oncology's Future Earnings
A Peek at Champions Oncology's Future Earnings
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.Champions Oncology (NASDAQ:CSBR) is gearing up to announce its quarterly earnings on Wednesday, 2024-12-11. Here's a quick overview of what investors should know before the release.
Champions Oncology (纳斯达克:CSBR) 正在准备于2024-12-11周三公布其季度财报。在发布之前，这里有投资者应了解的快速概述。
Analysts are estimating that Champions Oncology will report an earnings per share (EPS) of $0.01.
分析师估计，Champions Oncology 将报告每股收益（EPS）为0.01美元。
Anticipation surrounds Champions Oncology's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
市场对Champions Oncology的公告充满期待，投资者希望听到超出预期以及对下个季度的积极指引。
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
新投资者应理解，尽管盈利表现重要，但市场反应往往受指引驱动。
Historical Earnings Performance
历史财报表现
Last quarter the company beat EPS by $0.14, which was followed by a 9.58% increase in the share price the next day.
上个季度，该公司超出每股收益0.14美元，次日股价上涨了9.58%。
Here's a look at Champions Oncology's past performance and the resulting price change:
以下是Champions Oncology的历史表现及随之而来的价格变化：
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.03 | -0.16 | -0.15 | -0.17 |
| EPS Actual | 0.11 | 0.01 | -0.16 | -0.15 |
| Price Change % | 10.0% | 3.0% | -3.0% | 5.0% |
| 季度 | 2025年第一季度 | 2024年第四季度 | 2024年第三季度 | 2024年第二季度 |
|---|---|---|---|---|
| 每股收益预估值 | -0.03 | -0.16 | -0.15 | -0.17 |
| 每股收益实际值 | 0.11 | 0.01 | -0.16 | -0.15 |
| 价格变动百分比 | 10.0% | 3.0% | -3.0% | 5.0% |
Champions Oncology Share Price Analysis
Champions Oncology 股价分析
Shares of Champions Oncology were trading at $4.88 as of December 03. Over the last 52-week period, shares are up 0.41%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
截至12月3日，Champions Oncology的股价为4.88美元。在过去的52周内，股价上涨了0.41%。鉴于这些收益普遍积极，长期股东在此次财报发布前可能看好。
To track all earnings releases for Champions Oncology visit their earnings calendar on our site.
要查看Champions Oncology的所有财报发布，请访问我们网站上的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审核。